Faecal carriage of extended-spectrum beta-lactamase and carbapenemase-producing enterobacterales among HIV patients at Jimma Medical Center, Southwest Ethiopia
Open Access
- 6 November 2024
- journal article
- research article
- Published by Springer Nature in BMC Microbiology
- Vol. 24 (1) , 1-10
Abstract
Enterobacterales infections in immunocompromised individuals are associated with considerable morbidity, mortality, and health care costs. This study aimed to assess the faecal carriage of extended-spectrum β-lactamase (ESBL) and carbapenemase-producing Enterobacterales (CPE) among HIV-infected patients at Jimma Medical Center. A total of 344 stool samples were collected and inoculated on Mac-Conkey and Eosin-Methylene Blue agar and incubated at 35–37 °C aerobically. ESBL and carbapenemase production were detected using D68C ESBL/AmpC and D73C CARBA plus (Mast Group, UK). A total of 376 Enterobacterales were isolated. The prevalence of ESBL-PE and CPE carriage rate was 13.3% (50/376) and 4.3% (16/376) respectively. The highest proportion of ESBL producing isolates were found in K. pneumoniae 29.0% (9/31) followed by E. coli 13.4% (39/292). Similarly, K. pneumoniae 12.9% (4/31) was the most common carbapenem-resistant isolate followed by E. coli 3.8% (11/292). Multi-drug resistance was observed in 66.5% (250/376) of the isolates. Prior cephalosporin use (AOR = 7.9; 2.31–27.29), CD4 count (≤ 350 cells/µL) (AOR = 3.8; 1.12–12.9), and comorbidities (AOR = 2.3; 1.24–4.32) were significantly associated with ESBL production. Additionally, cephalosporin use (AOR = 6.34; 1.27–31.66) was significantly associated with the presence of CRE. This study revealed a high prevalence of ESBL-PE and CPE among HIV patients, with K. pneumoniae and E. coli being the dominant isolates. MDR was common, with key risk factors being prior cephalosporin use, low CD4 counts, and comorbidities. These findings emphasize the need for enhanced infection prevention and control, regular screening, and improved antibiotic stewardship to curb the spread of resistant bacteria in immunocompromised individuals.Keywords
This publication has 30 references indexed in Scilit:
- Extended-Spectrum β-Lactamase and Carbapenemase Producing Gram-Negative Bacilli Infections Among Patients in Intensive Care Units of Felegehiwot Referral Hospital: A Prospective Cross-Sectional StudyInfection and Drug Resistance, 2021
- Potential challenges to sustained viral load suppression in the HIV treatment programme in South Africa: a narrative overviewAIDS Research and Therapy, 2021
- High Prevalence of Fecal Carriage of Extended Spectrum β-Lactamase-Producing Enterobacteriaceae Among Newly HIV-Diagnosed Adults in a Community Setting in TanzaniaMicrobial Drug Resistance, 2020
- High prevalence of colonisation with carbapenem-resistant Enterobacteriaceae among patients admitted to Vietnamese hospitals: Risk factors and burden of diseaseJournal of Infection, 2019
- Epidemiology of and risk factors for infection with extended-spectrum β-lactamase-producing carbapenem-resistant Enterobacteriaceae: results of a double case–control studyInfection and Drug Resistance, 2018
- Tuberculosis: Smart manipulation of a lethal hostMicrobiology and Immunology, 2018
- Intestinal barrier and gut microbiota: Shaping our immune responses throughout lifeTissue Barriers, 2017
- Carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae in HIV-infected children in ZimbabweJournal of Medical Microbiology, 2017
- A review of 40 years of enteric antimicrobial resistance research in Eastern Africa: what can be done better?Antimicrobial Resistance & Infection Control, 2015
- The MAST® D68C test: an interesting tool for detecting extended-spectrum β-lactamase (ESBL)-producing EnterobacteriaceaeEuropean Journal of Clinical Microbiology & Infectious Diseases, 2015